Surendra Singh

Surendra Singh currently serves as the Vice President of Drug Substance Development and Manufacturing at Relay Therapeutics, a position held since July 2022, after previously holding the title of Senior Director at the same company from July 2019 to June 2022. With extensive experience in CMC development, Surendra has worked as an Independent CMC Consultant from 2012 to June 2019, managing activities across global vendor sites and supporting regulatory filings. Prior roles include Director of Chemistry Process Research at Sunovion Pharmaceuticals Inc. and Senior Process Scientist at Merck, where leadership in process development and regulatory support was demonstrated. Educational qualifications include a degree from The Ohio State University, completed between 1991 and 1994.